Maxwell GL - Search Results

1

Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.

Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC. Risinger JI, et al. Among authors: maxwell gl. Clin Cancer Res. 2007 Mar 15;13(6):1713-9. doi: 10.1158/1078-0432.CCR-05-2569. Clin Cancer Res. 2007. PMID: 17363524

2

Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.

Maxwell GL, Risinger JI, Gumbs C, Shaw H, Bentley RC, Barrett JC, Berchuck A, Futreal PA. Maxwell GL, et al. Cancer Res. 1998 Jun 15;58(12):2500-3. Cancer Res. 1998. PMID: 9635567

3

Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.

Maxwell GL, Risinger JI, Tong B, Shaw H, Barrett JC, Berchuck A, Futreal PA. Maxwell GL, et al. Gynecol Oncol. 1998 Jul;70(1):13-6. doi: 10.1006/gyno.1998.5039. Gynecol Oncol. 1998. PMID: 9698466

4

Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.

Carney ME, Maxwell GL, Lancaster JM, Gumbs C, Marks J, Berchuck A, Futreal PA. Carney ME, et al. Among authors: maxwell gl. J Soc Gynecol Investig. 1998 Sep-Oct;5(5):281-5. doi: 10.1016/s1071-5576(98)00018-5. J Soc Gynecol Investig. 1998. PMID: 9773405

5

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

Risinger JI, Hayes K, Maxwell GL, Carney ME, Dodge RK, Barrett JC, Berchuck A. Risinger JI, et al. Among authors: maxwell gl. Clin Cancer Res. 1998 Dec;4(12):3005-10. Clin Cancer Res. 1998. PMID: 9865913

6

Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.

Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC, Berchuck A. Maxwell GL, et al. Clin Cancer Res. 2000 Aug;6(8):2999-3005. Clin Cancer Res. 2000. PMID: 10955777

7

Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.

Maxwell GL, Risinger JI, Alvarez AA, Barrett JC, Berchuck A. Maxwell GL, et al. Obstet Gynecol. 2001 Mar;97(3):417-22. doi: 10.1016/s0029-7844(00)01165-0. Obstet Gynecol. 2001. PMID: 11239648

8

Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.

Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC. Risinger JI, et al. Among authors: maxwell gl. Cancer Res. 2003 Jan 1;63(1):6-11. Cancer Res. 2003. PMID: 12517768

9

Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers.

Risinger JI, Maxwell GL, Berchuck A, Barrett JC. Risinger JI, et al. Among authors: maxwell gl. Ann N Y Acad Sci. 2003 Mar;983:208-12. doi: 10.1111/j.1749-6632.2003.tb05975.x. Ann N Y Acad Sci. 2003. PMID: 12724225 Review.

10

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.

Maxwell GL, Chandramouli GV, Dainty L, Litzi TJ, Berchuck A, Barrett JC, Risinger JI. Maxwell GL, et al. Clin Cancer Res. 2005 Jun 1;11(11):4056-66. doi: 10.1158/1078-0432.CCR-04-2001. Clin Cancer Res. 2005. PMID: 15930340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters